English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Biopesticide NOFLY got approval for commercialization in Israelqrcode

Aug. 4, 2015

Favorites Print
Forward
Aug. 4, 2015

Follow

NOFLY has been recently approved for its trade in Israel as a biopesticide suitable for organic farming (ref. 7453) for the biological control of whiteflies, aphids and thrips, pathogenic insects that cause annually significant economic losses in crops worldwide. NOFLY is one of the leading products of Spainish company Futureco Bioscience, entirely developed and registered from Spain.

 
The bioinsecticide based on spores of the strain FE9901 of the entomopathogenic fungus Isaria fumosorosea began to develop in 2001, came to its definitive formulation in 2005 and began its registration for commercialization in the US and Canada in 2008 and in the EU in 2013, after eight years waiting for its final approval.
 
Besides the approval in Israel,  NOFLY is also commercialized in the US, Canada, Morocco, Kenya, Belgium and Italy, and is under registration in the remaining twenty-five countries of the EU and in Latin American countries such as Mexico, Brazil, Argentina, Chile, Colombia, Ecuador, Guatemala, Dominican Republic and Costa Rica.
 
NOFLY awarded European Union Prize of the Environment in the category of most innovative product in 2014 , representing a great example of environmental care, planning of crop protection respectful with the farmer and demonstration that perseverance and excellence in research is a safe bet.
Source: AgroNews

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox